1005502-63-5

Basic information

• Product Name: trans-4-(2-fluoro-benzoyl)-cyclohexanecarboxylic acid methyl ester
• Synonyms: trans-4-(2-fluoro-benzoyl)-cyclohexanecarboxylic acid methyl ester
• CAS NO: 1005502-63-5
• Molecular Weight: 264.297
• Mol File: 1005502-63-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: trans-4-(2-fluoro-benzoyl)-cyclohexanecarboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: trans-4-(2-fluoro-benzoyl)-cyclohexanecarboxylic acid methyl ester(1005502-63-5)
• EPA Substance Registry System: trans-4-(2-fluoro-benzoyl)-cyclohexanecarboxylic acid methyl ester(1005502-63-5)

Safety Data

• Hazardous Substances Data: 1005502-63-5(Hazardous Substances Data)

Upstream product

• 1072-85-1 o-fluorobromobenzene 
• 32529-80-9 trans-1-chlorocarbonyl-4-(methoxycarbonyl)-cyclohexane 
• 15177-67-0 trans-4-(methoxycarbonyl)cyclohexanecarboxylic acid 

Downstream Products

• 1345045-64-8 trans-4-(2-benzylsulfanyl-benzoyl)-cyclohexanecarboxylic acid methyl ester 
• 1429900-68-4 trans-4-benzo[d]isoxazol-3-yl-cyclohexanecarboxylic acid methyl ester 
• 1429900-65-1 trans-4-{(2-fluoro-phenyl)-[(E/Z)-hydroxyimino]-methyl}-cyclohexanecarboxylic acid methyl ester 

Relevant articles and documents

Cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes as V1a antagonists

The present invention provides 4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes, which act as V1a receptor modulators, and in particular as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea, male or female sexual dysfunction, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, anxiety, depressive disorders, obsessive compulsive disorder, autistic spectrum disorders, schizophrenia, and aggressive behavior.

HETEROBIARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES

The present invention relates to heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes of formula (I), wherein R1, R2 and R3 are as described herein. The compounds according to the invention act as V1a receptor modulators, and in particular as V1a receptor ant